Are sharia councils in the UK a cause for concern? Jenny Chryss reports. Read more
Sharia Law in Britain
Are sharia councils in the UK a cause for concern? Jenny Chryss reports.
The Satanic Cult That Wasn't
How Satanic abuse accusations in a north London suburb went global, despite being untrue.
Sexism in the City
A City banker gets £3 million payout for sexism at work. Why do such cases still happen?
Why drug resistance is considered a severe threat to public safety. Peter Marshall reports
Aid to Nepal
Why aid money pouring into Nepal after the earthquake is likely to be corruptly diverted.
When GPs should say no
Why are patients given unnecessary medical treatments? Should doctors just say no?
Mobeen Azhar investigates the rising popularity of 'chemsex' parties on London's gay scene
Rwanda: Has Britain Been Beguiled?
Has Britain got too close to Rwanda after its remarkable recovery from the 1994 genocide?
Jehovah's Witnesses and Child Sexual Abuse
Do Jehovah's Witnesses' child safeguarding policies adequately protect against abuse?
Radicals, Rights and Hunting - The Battle for the RSPCA
Peter Marshall investigates claims the RSPCA faces a takeover by animal rights radicals.
Kids Company: What's Going On?
The charity Kids Company and its founder Camila Batmanghelidjh are under fire. Why?
The Corbyn Effect
How has Jeremy Corbyn MP garnered so much support in Labour's leadership contest?
Tunisia on the Fault Line
Deserted beaches and empty hotels: a package holiday after the terror attack in Sousse.
E-Cigarettes: Another Puff
Are e-cigarettes a health hazard or the best aid we have for smokers trying to quit?
The IRA and Sexual Abuse
Mairia Cahill tells her story of sexual abuse at the hands of a senior IRA operative.
The Ambridge Price of Milk
The current milk crisis, seen through the prism of long-running radio soap The Archers.
The Hollywood Spy
Why British writer Cedric Belfrage avoided prosecution after passing top secrets to Russia
My Big Fat Greek Crisis
Can Greece turn its fortunes around? Frances Stonor Saunders asks the Greek people.
The 'Pink Pill': The Female Viagra?
Why the first licensed drug to treat low sexual desire in women is proving controversial.
How to Get Into the UK
The programme looks at who is eligible for a visa to live or work in the UK.
Salad v Surgery: Treating Type 2 Diabetes
Why an operation might be the best way to treat Type 2 diabetes
Peter Oborne's Chilcot Report
Peter Oborne gives his verdict on crucial questions raised by the 2003 invasion of Iraq.
Paris: Could it Happen Here?
Edward Stourton and 4 British Muslim journalists discuss the extremist threat to the UK
Changing Jihadi Minds
The secretive counter-extremism programme known as Channel is investigated by John Ware.
Young, Tory and Bullied
Investigating bullying allegations in the conservative youth movement. John Manel reports.
Al Qaeda in Syria
Has the west or its allies entered into an unspoken alliance with Al Qaeda in Syria?
A not so merry migrant Christmas in Vienna
Thousands of migrants are stuck in Vienna. Will they ever realise their European dreams?
Afghanistan: Time for Truth?
Is it time for the west to admit it lost the war in Afghanistan?
Should Labour MPs be scared of Momentum? Stephen Bush of the New Statesman finds out.
Litvinenko: The Miniature Nuclear Attack
The story behind the fatal poisoning in London of Russian exile Alexander Litvinenko.
Tommy Robinson's Pegida Ambition
Tommy Robinson launches the UK branch of the German anti-Islam group Pegida.
Lord Bramall: A Failure to Investigate?
The former army chief speaks on now-dismissed allegations of child abuse made against him
Trump v the Republicans in New Hampshire: PJ O'Rourke on the campaign trail
US satirist PJ O'Rourke goes on the campaign trail in New Hampshire. Can Trump really win?
What would a seven-day NHS look like, and can the government afford to pay for it?
Jimmy Savile and the BBC
How did Jimmy Savile get away with sexual abuse when so many people knew so much?
The gangland feud that led to two horrific murders within just four days in Dublin.
Can psychedelic drugs overcome their notoriety to become accepted for routine medical use?